Oncology Pharma Stock Price, News & Analysis
Company Description
Oncology Pharma (OTC Link: ONPH) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $3.8K.
This page provides a comprehensive overview of ONPH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Oncology Pharma (ONPH) stock last traded at $0.0761, down 23.90% from the previous close. At a market capitalization of $3.8K, ONPH is classified as a micro-cap stock with approximately 83.7M shares outstanding.
Latest News
Oncology Pharma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial. View all ONPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Oncology Pharma (ONPH) currently stands at 13.4 thousand shares, down 0.1% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Oncology Pharma (ONPH) currently stands at 3.8 days, up 69.4% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 88.9% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 18.5 days.
ONPH Company Profile & Sector Positioning
Oncology Pharma (ONPH) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ONPH often look at related companies in the same sector, including Kaleido Biosciences (KLDO), Rebus Hldgs Inc (RBSH), Cardax Inc (CDXI), Ampio Pharma (AMPE), and BETTER THERAPEUTICS INC (BTTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ONPH's relative position within its industry.